GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (MEX:PRGO) » Definitions » Cyclically Adjusted Price-to-FCF

Perrigo Co (MEX:PRGO) Cyclically Adjusted Price-to-FCF : 7.90 (As of Oct. 09, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Perrigo Co Cyclically Adjusted Price-to-FCF?

As of today (2024-10-09), Perrigo Co's current share price is MXN686.00. Perrigo Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 was MXN86.82. Perrigo Co's Cyclically Adjusted Price-to-FCF for today is 7.90.

The historical rank and industry rank for Perrigo Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

MEX:PRGO' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 7.46   Med: 13.23   Max: 68.38
Current: 7.52

During the past years, Perrigo Co's highest Cyclically Adjusted Price-to-FCF was 68.38. The lowest was 7.46. And the median was 13.23.

MEX:PRGO's Cyclically Adjusted Price-to-FCF is ranked better than
93.81% of 291 companies
in the Drug Manufacturers industry
Industry Median: 31.73 vs MEX:PRGO: 7.52

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Perrigo Co's adjusted free cash flow per share data for the three months ended in Jun. 2024 was MXN-2.526. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is MXN86.82 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Perrigo Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Perrigo Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Cyclically Adjusted Price-to-FCF Chart

Perrigo Co Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.51 11.53 10.53 9.35 9.12

Perrigo Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.78 9.14 9.12 9.49 7.90

Competitive Comparison of Perrigo Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perrigo Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Cyclically Adjusted Price-to-FCF falls into.



Perrigo Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Perrigo Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=686.00/86.82
=7.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perrigo Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Perrigo Co's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-2.526/122.3184*122.3184
=-2.526

Current CPI (Jun. 2024) = 122.3184.

Perrigo Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 16.324 100.474 19.873
201412 27.635 99.576 33.946
201503 25.564 99.975 31.277
201506 6.674 100.573 8.117
201509 11.204 100.274 13.667
201512 17.545 99.676 21.531
201603 16.300 99.676 20.003
201606 4.778 101.072 5.782
201609 25.839 100.274 31.519
201612 26.503 99.676 32.523
201703 22.618 100.374 27.563
201706 9.536 100.673 11.586
201709 22.887 100.474 27.863
201712 25.379 100.075 31.020
201803 20.429 100.573 24.846
201806 8.840 101.072 10.698
201809 16.404 101.371 19.794
201812 21.408 100.773 25.985
201903 10.454 101.670 12.577
201906 4.250 102.168 5.088
201909 15.066 102.268 18.020
201912 5.804 102.068 6.955
202003 23.568 102.367 28.161
202006 44.418 101.769 53.387
202009 3.034 101.072 3.672
202012 6.465 101.072 7.824
202103 -6.864 102.367 -8.202
202106 -15.689 103.364 -18.566
202109 46.380 104.859 54.102
202112 -22.536 106.653 -25.846
202203 8.737 109.245 9.783
202206 -6.771 112.779 -7.344
202209 5.664 113.504 6.104
202212 23.068 115.436 24.443
202303 -0.508 117.609 -0.528
202306 4.129 119.662 4.221
202309 11.795 120.749 11.948
202312 22.783 120.749 23.079
202403 -3.196 120.990 -3.231
202406 -2.526 122.318 -2.526

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Perrigo Co  (MEX:PRGO) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Perrigo Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Perrigo Co Business Description

Industry
Traded in Other Exchanges
Address
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.